AI has already made a massive impact on healthcare, especially in the fields of cardiology and radiology. With the FDA clearing more and more algorithms, this trend is only expected to grow as time goes on.

Dave Dixon, PharmD, explored the short- and long-term impact of these approvals, noting that they could help reduce costs down the line.

Howard Herrmann, MD,  MSCAI, Hospital of the University of Pennsylvania, and lead invesigator for the SMART trial, explains details on the 2-year data comparing the Evolut vs. Sapien 3 for TAVR in small annulus patients.

Use of the scoring system could offer providers valuable preoperative insight and help guide them in surgical decisions. 

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

These updates, which will be rolled out universally to existing users through the launch of v4.0, are designed to enhance usability, broaden access, and increase data security.

MedPAC members have highlighted the need to link physician pay increases with the Medicare Economic Index, a measure of practice cost inflation. 

As the use of AI in imaging continues to grow, it’s “become clear" that real world performance of these products can defer from premarket testing, experts note. 

In other news, the University of Nebraska Medical Center has named Ryan Lee, MD, MBA, as its next chair of radiology, while ASRT has elected new board members. 

In addition to serving 30 months behind bars, Wendell Lewis Randall, MD, is ordered to pay a $2 million fine for defrauding Medicare and Medicaid.